Fig. 4From: Neoadjuvant chemotherapy response in androgen receptor-positive triple-negative breast cancer: potential predictive biomarkers and genetic alterationsGenomic landscape differences between the pCR and non-pCR AR-positive TNBC patientsBack to article page
